Fintepla
Fintepla 360ML of 2.2MG/ML
¿Qué es Fintepla?
Fintepla (fenfluramina) es un medicamento con receta aprobado para el tratamiento de convulsiones asociadas con el síndrome de Dravet en pacientes de dos años de edad en adelante. Funciona reduciendo la frecuencia de las convulsiones convulsivas cuando se añade a otros medicamentos para las convulsiones, pero su mecanismo exacto de acción en el tratamiento de las convulsiones no se comprende completamente. Fintepla está clasificado como una sustancia controlada de la Lista IV debido a su similitud con el supresor del apetito fenfluramina, que fue retirado del mercado debido a preocupaciones de seguridad.Side Effects
- Decreased appetite
- Drowsiness
- Diarrhea
Warnings
- Risk of QT Prolongation and ventricular arrhythmia
- Increased risk of suicidal behavior and ideation
- Potential for somnolence or sedation which can impair the ability to perform tasks
- Possible interaction with other central nervous system depressants
Prescription savings · ·
¿Qué es Fintepla ?
Fintepla (fenfluramina) es un medicamento con receta aprobado para el tratamiento de convulsiones asociadas con el síndrome de Dravet en pacientes de dos años de edad en adelante. Funciona reduciendo la frecuencia de las convulsiones convulsivas cuando se añade a otros medicamentos para las convulsiones, pero su mecanismo exacto de acción en el tratamiento de las convulsiones no se comprende completamente. Fintepla está clasificado como una sustancia controlada de la Lista IV debido a su similitud con el supresor del apetito fenfluramina, que fue retirado del mercado debido a preocupaciones de seguridad.Fintepla Cupones y Precios - Rx.com
Fintepla 360ML of 2.2MG/ML
Weight-loss medication, prescribed online
Licensed U.S. providers · No insurance needed · Shipped to your door
Searching for a Fintepla coupon? Fintepla (fenfluramine) is a brand-only oral solution used alongside other anti-seizure medications to treat seizures caused by Dravet syndrome and Lennox-Gastaut syndrome, and because it's dispensed through a restricted pharmacy program, prices can vary widely from one pharmacy to the next — enter your ZIP above to compare today's price with Rx.com's free cash coupon, whether or not you have insurance.
What is Fintepla and how does it work?
Fintepla's active ingredient is fenfluramine, a serotonin-releasing agent (a 5-HT2 receptor agonist). Fenfluramine is the same drug substance that was previously sold for weight loss — including as part of the "fen-phen" combination (fenfluramine-phentermine) — and it was withdrawn from the U.S. market in 1997 after it was linked to valvular heart disease and pulmonary hypertension at the higher doses used for weight loss. Fintepla uses much lower doses of that same substance for a different purpose: as an add-on treatment to help control seizures, not for weight loss. Because Fintepla contains the same drug substance tied to those earlier heart risks, it carries a boxed warning and requires regular echocardiogram monitoring throughout treatment (see Safety information below).
The FDA has approved Fintepla oral solution as an add-on (adjunctive) therapy for seizures associated with Dravet syndrome and Lennox-Gastaut syndrome (LGS) in patients 2 years of age and older. It's meant to be used together with a patient's other anti-seizure medications, not typically as a stand-alone treatment.
Fintepla coupon vs. the manufacturer savings card
Fintepla's manufacturer offers its own savings program through the official Fintepla website, but like most brand drug-maker cards, it's generally limited to patients with commercial (private) insurance, and the exact terms, eligibility rules, and any coverage caps can change — check the manufacturer's site directly for current details. There is currently no generic version of Fintepla, so brand pricing is the only option, and cost can vary a lot by pharmacy.
If you're uninsured, on Medicare, or the manufacturer's card doesn't apply to you, Rx.com's free cash coupon can still help. Because Fintepla is only dispensed through a restricted REMS (Risk Evaluation and Mitigation Strategy) pharmacy network, not every pharmacy carries it — enter your ZIP above to find participating pharmacies near you and compare cash prices. If you don't qualify for the manufacturer's savings card, it's also worth asking your prescriber's office or the manufacturer whether any additional patient support options are available.
Other seizure medications for Dravet syndrome and LGS
Fintepla is one of several add-on anti-seizure treatments prescribed for Dravet syndrome and Lennox-Gastaut syndrome. Depending on the specific diagnosis and other medications a patient is already taking, a doctor might also consider Epidiolex, Onfi or its generic clobazam, Banzel, or Diacomit.
These medications work differently and have their own dosing, monitoring, and side-effect profiles, so switching or adding a seizure medication should always be guided by the prescribing neurologist — this isn't a decision to make based on cost alone.
Fintepla safety information
Fintepla carries a boxed warning for valvular heart disease (VHD) and pulmonary arterial hypertension (PAH). Because of this, patients need an echocardiogram before starting treatment, every 6 months while taking it, and again roughly 3 to 6 months after stopping. Fintepla is only available through a restricted REMS program that requires the prescriber, pharmacy, and patient to all be enrolled.
Other reported effects include decreased appetite and weight loss, somnolence (sleepiness/sedation), and — as with other anti-seizure medications — a rare risk of suicidal thoughts. Fintepla can also interact with other serotonergic or CNS-active drugs. This is general information, not medical advice; talk with your prescriber or pharmacist about your specific situation and full medication list.
La información sobre Fintepla fue redactada y revisada con base en fuentes médicas autorizadas de EE. UU. (MedlinePlus, de la Biblioteca Nacional de Medicina de EE. UU.; DailyMed; y la información de prescripción de la FDA) y verificada para asegurar su precisión. Se ofrece con fines educativos y no sustituye el consejo médico profesional.
Consulte la etiqueta oficial: Fintepla en DailyMed (FDA)
Revisado con base en el etiquetado de la FDA · Última revisión: julio de 2026
Browse more medications: starting with F · full A-Z directory · by condition · common drugs
Medical disclaimer: This information is provided for general educational purposes only and is not medical advice. It is not a substitute for professional diagnosis or treatment. Always consult a licensed physician, pharmacist, or other qualified healthcare provider before starting, stopping, or changing any medication or treatment. Never disregard professional medical advice or delay seeking it because of something you read here. If you think you may have a medical emergency, call your doctor or 911 immediately.